Professor Hussain Abdulrahman Al-Omar

Professor Hussain Al-Omar is a Consultant and Professor of Pharmacoeconomics and Pharmaceutical Policy at King Saud University. Professor Al-Omar received his Ph.D. from the Faculty of Life Sciences and Medicine at King’s College London, UK, and holds an executive education degree in business strategy and financial performance from the Institut Européen d’Administration des Affaires (INSEAD), France.

Complementing his formal degrees, Professor Al-Omar has undertaken advanced training in health technology assessment (HTA), health economics, HTA processes and methods for health technologies, and quantitative and qualitative research in health economics at leading UK institutions, including the University of Oxford, the University of York, and the National Institute for Health Research.

With over 26 years of experience, Professor Al-Omar is a recognized strategic leader who has driven transformative advancements in health systems at national, regional, and global levels. Beyond his academic role, he has held several senior executive and advisory positions, including serving as the Executive Director of the Center for Health Technology Assessment and as an advisor to a number of HTA bodies and regulatory agencies.

Professor Al-Omar is a recognized expert in health strategy and policy, HTA, pricing and reimbursement, value-based healthcare, and value-based contracting. His leadership has contributed to shaping numerous national, regional, and international health policies, strategic projects, and initiatives, all aimed at enhancing the sustainability and efficiency of health systems and service delivery.

Professor Al-Omar brings a distinctive combination of strategic, scientific, operational, and leadership expertise and is regarded as a role model by many aspiring and established professionals in the fields of HTA and Health Economics and Outcomes Research. His deep technical knowledge of HTA, pricing, reimbursement, and value-based contracting and procurement across pharmaceuticals, medical devices, diagnostics, digital health, and artificial intelligence has established him as a leading expert in the field across the region.